Capricor Therapeutics Inc.

In News

FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection - Fierce Biotech

Fierce Biotech - Mar 10, 2026

Capricor Therapeutics (CAPR) Valuation After Positive Phase 3 HOPE-3 Results for DMD Therapy Deramiocel - Yahoo Finance

Yahoo Finance - Dec 03, 2025

Capricor Therapeutics (CAPR) Leads Healthcare Stocks with High F - GuruFocus

GuruFocus - Apr 17, 2026

Capricor Therapeutics director sells $3.5m in shares - Investing.com

Investing.com - Apr 01, 2026

Capricor Therapeutics (CAPR) director sells 7,529 exercised shares - Stock Titan

Stock Titan - Apr 03, 2026

Capricor Therapeutics Announces Positive Topline Results - GlobeNewswire

GlobeNewswire - Dec 03, 2025

Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court (CAPR) - Seeking Alpha

Seeking Alpha - Dec 03, 2025

Capricor Therapeutics to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - Quiver Quantitative

Quiver Quantitative - Mar 09, 2026

Capricor Therapeutics (CAPR) Reports Positive Phase 3 HOPE-3 Data and $318M 2025 Cash Balance - Yahoo Finance

Yahoo Finance - Mar 17, 2026

Capricor Therapeutics (NASDAQ: CAPR) details 2026 meeting, board elections, pay and Deramiocel deals - Stock Titan

Stock Titan - Apr 10, 2026

Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference - GlobeNewswire

GlobeNewswire - Feb 24, 2026

Capricor Therapeutics Inc (CAPR) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment